LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study

CompletedOBSERVATIONAL
Enrollment

727

Participants

Timeline

Start Date

March 5, 2021

Primary Completion Date

May 18, 2023

Study Completion Date

May 18, 2023

Conditions
Atrial FibrillationSyncopeCryptogenic Stroke
Trial Locations (24)

10025

Mount Sinai Morningside, New York

19104

Presbyterian University of Pennsylvania Medical Center, Philadelphia

23507

Sentara Norfolk General Hospital, Norfolk

27607

North Carolina Heart and Vascular Research, Raleigh

32308

Tallahassee Memorial Hospital, Tallahassee

33432

Cardiac Arrhythmia Service, Boca Raton

35801

Heart Center Research, LLC, Huntsville

37403

Erlanger Medical Center, Chattanooga

39216

University of Mississippi Medical Center, Jackson

43615

The Toledo Hospital, Toledo

44710

Aultman Hospital, Canton

45242

Bethesda North Hospital, Cincinnati

52242

University of Iowa Hospitals and Clinics, Iowa City

57701

Monument Health Rapid City Hospital, Rapid City

65807

Cox Health, Springfield

66211

Kansas City Arrhythmia Research LLC, Kansas City

72401

Arrythmia Research Group, Jonesboro

78705

Texas Cardiac Arrhythmia Research, Austin

83712

St. Luke's Idaho Cardiology Associates, Boise

86001

Northern Arizona Healthcare, Flagstaff

92037

Scripps Memorial Hospital, La Jolla

93003

Cardiology Associates Medical Group, Ventura

98664

PeaceHealth Southwest Medical, Vancouver

07103

Rutgers New Jersey Medical School, Newark

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY